Globe Life Inc.
GL
NYSE·Financial Services·Insurance - Life·Mkt cap $13.7B
$174.27
▼ -1.27%
P/E
11.50
Mkt Cap
$13.7B
52-Wk Range
$127.85–$191.55
52-Week Range
$127.85 - $191.55
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 24.8% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Niche market focus on middle-income households
- Diverse and complementary insurance product lines
- Strong regional presence in the United States
- Cost-effective insurance solutions
Bear Case
2 risks
- Low volatility (beta 0.5).
- Premium valuation to Life Insurance peers
Growth
Stable outlook
Expanding digital insurance distribution channels
Value
Premium valuation to Life Insurance peers
Momentum
Strong
+14.4% over 3m
Quality
Thin
Strong fundamentals
Dividend
Modest
0.68% yield
Smart-money signal
Who's buying GL right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Oct 28, 2026
JUL 22, 2026
Reported EPS of $3.61 vs $3.67 consensus (-1.6% surprise). Revenue of $1.6B vs $1.6B expected (+0.6%).
EPS surprise · last 4Q
0 of 1 beats
Estimate
Actual
Q3 26
-1.6%
Revenue trend · last 8Q
—
+3%
+4%
+3%
+4%
+7%
+5%
+8%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$1.4B
$1.4B
$1.5B
$1.5B
$1.5B
$1.5B
$1.6B
$1.6B
Margins · last 8Q
Gross
-48.1%
Operating
-23.0%
Profit
18.0%
Wall Street consensus
6 analysts · 83% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
83%
Hold
17%
Sell
0%
Median Price Target
—
Latest: Piper Sandler · Jul 15, 2026
vs Industry
How GL stacks vs Insurance - Life
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related